Investigation of the relationship between peak vertical accelerations and aerobic exercise intensity during graded walking and running in postmenopausal women by Gil Rey, Erreka et al.
                          Gil Rey, E., Deere, K. C., Malado-Samperdon, S., Palacious-Samper,
N., Azpeitia, A., Gorostiaga, E. M., & Tobias, J. H. (2020).
Investigation of the relationship between peak vertical accelerations
and aerobic exercise intensity during graded walking and running in
postmenopausal women. Journal of Aging and Physical Activity.
https://doi.org/10.1123/japa.2019-0256
Peer reviewed version
Link to published version (if available):
10.1123/japa.2019-0256
Link to publication record in Explore Bristol Research
PDF-document
This is the author accepted manuscript (AAM). The final published version (version of record) is available online
via Human Kinetics at https://doi.org/10.1123/japa.2019-0256. Please refer to any applicable terms of use of the
publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the
published version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/






How exercise intensity targets, calibrated according to oxygen consumption, relate to vertical 
impacts during weight bearing exercise is currently unknown. We investigated the 
relationship between vertical peaks (VPs) and metabolic equivalents of oxygen consumption 
(METs) in 82 women during walking and running. The magnitude of VPs, measured using a 
hip-worn triaxial accelerometer, was derived at recommended aerobic exercise intensity 
targets. VPs were 0.63 ± 0.18g at the lower recommended absolute exercise intensity target (3 
METs), but >1.5g at the upper end of moderate intensity activities (1.90 ± 1,13g at 6 METs). 
Multilevel linear regression analyses identified speed and type of locomotion as the strongest 
independent predictors of vertical peaks, explaining 54% and 11% of variance respectively. 
We conclude that, in contrast to lower intensities, exercising close to or above the 6-MET 
threshold generates VPs of osteogenic potential, suggesting this could provide simultaneous 
benefits to decrease all-cause mortality and osteoporosis risk.  
Keywords: Accelerometry, postmenopusal women, physical activity, metabolic equivalent, 
lactate threshold. 
  





Investigation of the Relationship between Peak Vertical Accelerations and Aerobic 
Exercise Intensity during Graded Walking and Running in Postmenopausal Women 
Physical activity (PA) constitutes an important strategy against premature death and 
chronic disease (Arem et al., 2015). Observational prospective cohort studies using self-
reported questionnaires suggest that meeting current PA guidelines (Riebe, Ehrman, Liguori, 
& Magal, 2017) of 150 min·wk-1 of moderate-to-vigorous physical activity (MVPA) reduces 
all-cause mortality risk by 26-31% (Arem et al., 2015). In addition, the beneficial effects of 
mechanical loading on the skeleton are well recognised (Katarina T. Borer, 2005). The US 
National Health and Nutrition Examination Survey (NHANES 2007-2010) showed that 
women who reported PA levels 2-4 times higher than the amount of PA recommended by 
guidelines (Riebe et al., 2017) had higher hip bone mineral density (BMD) (Whitfield, Kohrt, 
Pettee Gabriel, Rahbar, & Kohl, 2015). People reporting greater vigorous intensity activities 
show even higher benefits in mortality and bone outcomes compared to the same volume of 
moderate intensity activities, suggesting that PA intensity contributes to such benefits 
(Johansson, Nordstrom, & Nordstrom, 2015; Wen et al., 2011).  
Physical activity intensity is generally defined in terms of absolute rates of energy 
expenditure (3-6 METs for moderate intensity) (Garber et al., 2011). However, with 
increasing age or decreasing cardiorespiratory fitness (CRF), an activity at a given absolute 
intensity (MET) requires a greater percentage of the maximum oxygen uptake or V̇O2max (i.e., 
relative intensity) (Garber et al., 2011; Howley, 2001). Therefore, using the absolute intensity 
approach may not be the most accurate option for exercise programing or measuring PA 
outcomes in samples varying in age or CRF (Miller, Strath, Swartz, & Cashin, 2010; Ozemek, 
Cochran, Kaminsky, Strath, & Byun, 2013). Alternatively, the relative intensity approach 
measured either through a percentage from the V̇O2max or cardiac response (i.e., heart rate, 





HR) achieved during an exercise test to volitional fatigue, or throught the measurement of 
physiologic breakpoints of energy supply as lactate thresholds (LT) during submaximal 
exercise, are preferred for a tailored exercise intervention, and they provide a more 
homogeneous exercise dose among a group of individuals (Binder et al., 2008; Faude, 
Kindermann, & Meyer, 2009; Meyer, Gabriel, & Kindermann, 1999). 
However, though useful in describing metabolic and cardiovascular benefits of PA, 
this may be less tractable when examining skeletal health. For example, PA is thought to 
improve skeletal health by producing deformations (‘strains’), to which the skeleton responds 
in a dose-response manner (Clinton & Lanyon, 1984). Therefore, to evaluate potential 
benefits for skeletal health, it may be more appropriate to measure PA exposure in terms of 
the level of impact. Traditionally, accelerometers, which are widely used to provide objective 
measures of PA, are calibrated in terms of METs, however more relevant parameters for 
skeletal health, such as vertical impacts (VPs), can also be derived. Using this approach, cross 
sectional studies have identified relationships between the number of VPs, including higher 
impacts achieved during weight bearing exercise, and measures of skeletal health. For 
example, VPs which are four times above gravitational force (corresponding to running at or 
above 10 km·h-1 or jumping exercises) show the strongest relationships with hip and lumbar 
spine BMD in children (Deere, Sayers, Rittweger, & Tobias, 2012) and adult women (Stiles, 
Metcalf, Knapp, & Rowlands, 2017; Vainionpää et al., 2006; Winters-Stone et al., 2011). In 
addition, habitual exposure to lower VPs (~1.5g-s) can contribute to greater bone size and 
strength in older women (Hannam et al., 2017). This evidence suggests that impact exercise is 
site-specific and that the optimal dose may vary between different bone sites, sex and age 
groups. 





 In the present study, we wished to examine whether targets for PA intensity, defined in 
terms of METs, are also likely to confer benefits for skeletal health. We were particularly 
interested in postmenopausal women because they usually report lower MVPA compared to 
men (Kujala et al., 2017; Tucker, Welk, & Beyler, 2011), and because they have an increased 
risk of osteoporosis and cardio-metabolic diseases related to menopause, lower fitness and 
inactivity (Kanis et al., 2012; Kannel, Hjortland, McNamara, & Gordon, 1976). Therefore, we 
aimed to relate recommended absolute rates of energy expenditure and relative intensities 
(Garber et al., 2011; Riebe et al., 2017) (i.e., relative to V̇O2max and to lactate thresholds), to 
VPs, determined in postmenopausal women walking and jogging at a range of velocities. 
Furthermore, we aimed to identify factors predicting amplitude of VPs achieved during 
testing. In this way, we aimed to provide a basis for individualized PA recommendations in 
postmenopausal women, intended to achieve a wide range of health benefits including 
reduced risk of osteoporotic fracture.  
Method 
Participants 
Eighty-eight postmenopausal women who were recruited via advertisements placed in 
health medical centers performed; 1) a submaximal incremental shuttle test (IST), and 2) 
several (two to seven) constant velocity tests using a hip-worn triaxial accelerometer with 
measures of impact loading, HR and blood lactate, and 3) additional cardiopulmonary 
exercise tests including measures of oxygen uptake (V̇O2). Inclusion criteria were: 1) age <75 
years, and 2) surgical or natural menopause (no menstrual periods during previous 12 
months). Participants were excluded from the study if they had any of the following 
conditions that might interfere with exercise testing: 1) presence of spine or low-trauma 
fractures or severe arthrosis at the hip, knees or feet, 2) functional limitation to walk for 20 





minutes, 3) presence of any chronic disease that would impair the cardiorespiratory system 
during testing. The local hospital´s ethical committee approved the study (Pyto2011/71) and 
written informed consent was obtained from all participants before any study procedures were 
undertaken. The procedure of the study was in accordance with the Declaration of Helsinki 
and was registered in ClinicalTrials.gov PRS (NCT02984553). 
Exercise testing 
Submaximal Incremental shuttle test (IST).  Prior to the first visit, participants were 
instructed to abstain from caffeine and stimulants for at least four hours and strenuous activity 
for ≥24 h before testing. Before starting the test each participant´s HR (Polar V800, Polar 
Electro Oy, Kempele, Finland) and blood lactate concentration ([La-]) (Arkray KDK 
Corporation, Lactate Pro LT-1710, Shiga, Japan) were measured on a standing position. 
Capillary blood samples (0.3 µL) were taken from a hyperemic earlobe. Testing was 
performed in a laboratory setting in a controlled temperature environment (~20º) over a 20 m 
indoor track. The distance of the course was extended to 20 m from the original test (Singh, 
Morgan, Scott, Walters, & Hardman, 1992) to keep the pace constant avoiding excessive 
turns that might increase the energy cost and musculoskeletal demand, potentially leading to 
premature fatigue, discomfort or even injury. The exercise test protocol has been previously 
described and can be consulted elsewhere (Gil-Rey, Maldonado-Martín, Palacios-Samper, & 
Gorostiaga, 2018). Briefly, five cones were positioned at 0.5–5–10–15 and 19.5 m and 
participants had to walk in a straight line until the last cone, then turn around and return to the 
start.The speed was dictated by an audio signal. The IST started at 2.4 km·h-1 (~2.1 METs). 
The intensity was progressively increased by 0.61 km·h-1 (Singh et al., 1992) at each 2-min 
stage with 1-min rest in between. At the end of each stage, HR and [La-] were recorded.  





Each participant was free to start running from the 7th stage onwards (6.1 km·h-1), or 
the operator suggested to do so when the participant was not able to match the required speed. 
The test was stopped when: 1) [La-] values were ≥3.0 mmol·l-1 to avoid excessive fatigue, 
and/or 2) participant repeatedly (if they were one cone behind in two successive occasions)  
failed to match the pace programmed, and/or 3) participant was exhausted. The first lactate 
threshold (LT1) was defined as the highest velocity above which [La-] increased by an 
amount of ≥0.1 mmol·l-1 in the following stage and ≥0.2 mmol·l-1 in the subsequent stage.  
Constant velocity tests (CVT).  Participants completed two to seven 20 min CVT on 
the same 20 m track used for the IST. Each participant performed the corresponding tests on 
separate testing days (one week in between). Each CVT consisted of two stages of 10 min at a 
constant pace with a two minutes interruption for blood sampling. Heart rate was 
continuously recorded, and capillary blood samples were obtained before at rest, at the 10th 
min and the end of exercise (22nd min). Walking or running velocity of the first CVT was 
programmed as the velocity at which blood lactate increased by 1 mmol·l-1 above the blood 
lactate value at LT1 during the IST. In the following tests, the velocity was increased or 
decreased by ~0.30 km·h-1 until the maximal lactate steady state velocity (i.e., LT2) could be 
determined (Billat, Dalmay, Antonini, & Chassain, 1994). This is the reason why the 
participants had different number of CVTs. An increase in [La-] ≤0.4 mmol·l-1 during the final 
10 min of exercise was defined as steady state (Beneke, 2003). 
Cardiopulmonary exercise tests with gas exchange analysis.  A sub-group of 
randomly selected 30 participants performed two additional exercise tests. First, they repeated 
the IST wearing the same accelerometer on a treadmill ergometer (Kuntaväline, Hyper 
Treadmill 2040, Finland) with continuous gas exchange analysis in order to relate 
recommended exercise intensities (in METs) with VPs. At the end of each stage, capillary 





blood sampling from hyperaemic earlobe for [La-] analysis was performed until the velocity 
of LT2 from the track test was overcome. With a minimum of one week in between, 
participants performed a maximal cardiopulmonary exercise test on the same treadmill 
ergometer for the determination of V̇O2max. After 3-min rest, participants walked at 4.9 km·h
-1 
for a minute. Then, the speed was increased and maintained in 5.5 km·h-1 and the inclination 
of the treadmill was increased by 0.5% and by 1.3% in the first and next 1-min stages, 
respectively, to induce a ~0.6METs increment per stage until volitional fatigue. The perceived 
exertion was rated by a modified Borg´s scale (Borg, Ljunggren, & Ceci, 1985). A capillary 
blood sample was taken for lactate analysis at the termination of exercise, and 1, 3 and 5 
minutes later when the blood lactate continued increasing. All metabolic data were averaged 
over 30-second periods with the highest 1-min V̇O2 recorded as V̇O2max. Achievement of 
V̇O2max was assumed in the presence of a minimum of three of the following criteria: (1) 
failure of V̇O2 and/or HR to increase with further increases in workload, (2) individual´s 
volitional fatigue, rating a perceived effort of a minimum of 8 points out of 10 (Borg et al., 
1985), (3) elicited an exercise maximum HR (HRmax) that exceeded 85% of the individuals 
age-predicted maximum based on the HRmax estimated by 208-0.66·age (Edvardsen, Hansen, 
Holme, Dyrstad, & Anderssen, 2013), (4) RER ≥1.10, and (5) Maximum [La-] (BLCmax) >8 
mmol·L-1 (Mezzani et al., 2013). 
 Inmediatelly after cessation of each exercise test, gas analysers drift was verified and 
V̇O2 values were corrected following procedures previously described (Garcia-Tabar, 
Eclache, Aramendi, & Gorostiaga, 2015). 
Accelerometry data 
Each participant wore a triaxial accelerometer (Actigraph wGT3X-BT Pensacola, FL, 
USA) over the right iliac crest in the mid-axillary line throughout the tests, as vertical as 





possible attached to an elastic belt around the waist. Each monitor was previously initialized 
at 50Hz frequency and raw acceleration files were downloaded in Actilife 6® full software 
(Actigraph, Pensacola, FL, USA). The acceleration of gravity (9.81 m/s2 = 1g) was 
subtracted, expressed as Euclidean Norm minus One (ENMO) and initial values of the three 
axes in a static standing position during three minutes were corrected to eliminate any 
inclination of the device. The average of the 20 highest acceleration peaks, identified based on 
accelerations that were higher than preceding and subsequent reading,  on vertical (V), 
anterior-posterior (AP) and media-lateral axis (ML) were selected to represent acceleration 
magnitudes of each speed (Hannam et al., 2017). 
Other measures 
Stature was measured using a wall stadiometer (Seca, Germany) and body mass was 
measured using a scale to the nearest 0.1kg (Seca, Germany). Leg strength was measured 
using the leg press (Technogym, Italy) one repetitium maximum (1-RM) test. Participants 
started performing 5-6 repetitions with a mass of 40kg and the load was progressively 
increased until the participant was not able to lift one repetition. During the test, speed and 
power of each lifting was monitored with T-Force dynamic measurement system (Ergotech, 
Spain) and was used to determine the number of repetitions with each load. In the case of two 
consecutive dropping repetitions (speed decrement), lifting was stopped to avoid excessive 
fatigue (Pareja‐Blanco et al., 2017). 
Statistical analysis 
Means and standard deviations (SD) were determined for participant demographics. 
Repeated measures ANOVAs were used to assess whether acceleration peaks were different 
across axes at each speed, across lower and upper moderate intensity boundaries according to 
absolute (METs) or relative (LT and %V̇O2max) intensity criteria, as well as across the range 





of walking and running velocities at each axis. The magnitude of the differences were 
assessed with Cohen´s effect-sizes (0.2 = small, 0.5 = medium, ≥0.8 = large). Where 
sphericity was violated, the Greenhouse-Geisser correction factor was applied. Post-hoc 
analyses were carried out using pairwaise comparisons with alpha (0.01) adjusted using 
Bonferroni correction.  
A subgroup of 30 participants performed an additional IST on a treadmill to measure 
the rates of metabolic energy expenditure (METs). A 3rd order (cubic) polynomial equation 
(R2 = 0.998) between vertical acceleration peaks (y) and METs (x) was used to determine the 
corresponding magnitude of VPs at the recommended exercise intensities (i.e., 3 and 6 METs) 
by standard public guidelines (Garber et al., 2011). The level of significance was set at p < 
0.05. Statistical analyses were performed using SPSS statistical software (version 22.0, IBM 
SPSS Statistics, Chicago, IL) and GraphPad Prism 7 was used for figures. 
To identify factors which predicted maximum VP, relationships between speed, type 
of locomotion, physical fitness exposures (aerobic fitness and leg strength), anthropometric 
characteristics (age, body mass and stature) and VPs were examined using univariate linear 
regression analysis. To identify the independent effect of each variable, all factors (speed, 
type of locomotion and footwear) and covariates (age, body mass, stature, leg strength and 
aerobic fitness), were adjusted in the same multivariate model. Partial Eta-square (η2) 
represents the explained proportion of the variance of the dependent variable after controlling 
for other factors. Coefficients represent the percentage change in outcome per SD change in 
exposure. Multilevel linear mixed-effect analysis was used to determine and estimate the 
effect of independent variables on VPs, as it can handle unbalanced data sets and take into 
account individual trends for regression analysis. Vertical peak measures are grouped per 
participant considering a multilevel data structure. As the number of velocity stages and 





locomotion varied across individuals (participant´s dependent), participant, speed, locomotion 
(0 = walking, 1 = running) and the interaction between speed and locomotion were entered as 
random-effects factors. The models included participant-related characteristics which were 
found to be independently associated with VPs (age, leg strength and aerobic fitness) as 
fixed–effects factors. Non-significant factors (p > 0.05) were excluded from the model.  
Model fit was subsequently evaluated (R2 and Akaike´s Infromation Criterion) and 
cross validated in a randomly selected 80% of the sample. This training data set was 
subdivided in five groups who were used to develop the models, leaving the remaining 20% 
assigned to the test dataset to be used to cross validate the models (Neugebauer, Collins, & 
Hawkins, 2014). Model assumptions (linearity of the relationships, normality and 
homoscedasticity of residuals) were checked via residual analysis (Q-Q plots and summary 
diagnostics) to ensure that both the prediction equation and the single-number summaries of 
the prediction accurately represent the full dataset. SAS/STAT statistical software (version 
14.3) was used for linear mixed-effect analysis.  
Results 
Among 102 interested participants who were screened by telephone for eligibility, 14 
were excluded. Reasons for exclusion were; 1) not meeting inclusion criteria/reported any of 
the exclusion criteria (n = 12), and 2) declined to participate (n = 2). Among 88 participants 
who were invited to the Medicine Center, 82 completed the exercise tests and were included 
in the study for data analysis (Table 1). Reasons for exclusion in data analysis were inability 
to walk-run for 20min due to musculoskeletal pain or discomfort that interfered with exercise 
tests (n = 5), and diagnosed cardiovascular disease (n = 1). One of the sub-group study 
participants was excluded from data analysis due to not-meeting maximal exercise criteria. 
The final 29 participants had a V̇O2max of 10.0 ± 4.2 METs (Table 2). 





Figure 1 shows triaxial acceleration peaks of the whole group during the IST. Across 
all walking stages, V and AP acceleration peaks showed a similar pattern, although higher 
acceleration peaks were observed in the V axis (p < 0.01, ES = 0.42‒0.62). Beyond 6.7 
km·h-1, when the majority of participants were running, greater inter-subject variability was 
observed, with a stepper increase in the magnitude of VPs compared to AP peaks (p < 0.01, 
ES = 1.36–2.02). Medial-lateral peaks remained lower (p < 0.01) than the other two axes 
across all velocities. A similar pattern was observed when only participants completing the 
8.5 km·h-1 stage (n = 18) were considered. 
Figure 2 shows the V̇O2 (in METs) and the VPs across the velocity stages of the IST 
performed on the treadmill by the sub-group of study participants (n = 29). Mean VP 
magnitudes at the recommended absolute moderate intensity thresholds were 0.63 ± 0.18g at 
3 METs (corresponding to a velocity of 3.2 km·h-1), and 1.90 ± 1.13g and at 6 METs (6.61 
km·h-1). The magnitudes of the VPs achieved at the lower boundary of moderate intensity 
according to relative intensity criteria (i.e., 46% V̇O2max or at LT1) were significantly higher 
compared to the clasiccal 3 METs boundary according to absolute intensity criteria (1.20 ± 
0.09g at 46% V̇O2max, p < 0.01; 95%CI: 0.364 to 0.790; ES: 8.91, and 1.16 ± 0.08g at LT1 
which corresponded to 4.6 ± 0.7 METs or a velocity of 5.5 km·h-1, p < 0.01; 95% CI: 0.359 
to 0.710; ES: 8.91). Measured VPs at the upper boundary of moderate intensity were highest 
at their maximal lactate steady-state velocity (i.e., LT2) (2.47 ± 0.20g) compared to the 
classical absolute intensity 6 METs boundary (1.90 ± 1.15g, p < 0.05; 95% CI: -0.179 to 
1.317; ES: 0.69) or the relative intensity boundary anchored at 63% V̇O2max (1.88 ± 1.14g, p 
< 0.01; 95%CI: 0.213 to 0.978; ES: 0.72). The corresponded velocity at LT2 was 7.3 km·h-1 
or an energy expenditure of 7.3 ± 1.9 METs during the 2-min exercising at that velocity 
during the IST. 





In subsequent analyses intended to identify the determinants of maximum VPs, all 
factors (speed, type of locomotion, footwear) and covariates (age, aerobic fitness, leg 
strength, body mass) except stature were found to be related maximum VPs in univariate 
analyses (Table 3). Age was the only factor showing an inverse association with VPs [β 
(95% CI) = -0.03 (-0.05, -0.02), p < 0.01]. In multivariate analyses, speed [β (95% CI) = 
0.29 (0.27, 0.31), p < 0.01] and type of locomotion [0.70 (0.55, 0.86), p < 0.01] were 
independently positively related to VPs, explaining 54% and 11% of the variance in VPs 
after adjusting for all factors and covariates (p < 0.01) . Leg strength, aerobic fitness and age 
also showed a weak independent association with VPs explaning less than 5% of their 
variation (p < 0.01) (Table 3). The multilevel linear mixed model identified speed, 
locomotion and age as the best fitting variables in terms of AIC and log likelihood estimates 
(equation 1).  
VP = 1.2911 ‒ 0.00642· (age ‒ 58.77) + 0.2999 · (speed ‒ 5.16) + 0.5333 · (locomotion) ‒ 
0.03445 · locomotion · (age ‒ 58,77) + 0.1613 · (speed ‒ 5.16) · locomotion (eq. 1) 
Where: a value of 0 is assigned if the mode of locomotion is walking and a value of 1 
is assigned to running. 
The Bland-Altman method between predicted and actual VPs against their mean for 
eq. 1 showed good agreement and moderate 95% individual limits of agreement [-0.12 
(0.71)g-s]. The slope of the regression line was significantly different from zero (p < 0.05), 
showing higher bias at higher VPs (particularly above 2g-s) (suppl. Figure 1). 
Discussion 
Our results suggest that the 3-MET threshold, classically established as the minimum 
exercise intensity required for reducing all-cause and cardiovascular mortality risk, is 





unlikely to decrease osteoporosis risk in postmenopausal women; the associated level of 
vertical impacts (0.63 ± 0.18g) is well below that previously found to be positively related to 
indices of bone strength (~1.5g), including in older postmenopausal women (Ahola, 
Korpelainen, Vainionpää, Leppäluoto, & Jämsä, 2009; Bassey, Rothwell, Littlewood, & 
Pye, 1998; K. T. Borer, Fogleman, Gross, La New, & Dengel, 2007; Hannam et al., 2017; 
Vainionpaa et al., 2007). On the other hand, walking or jogging at higher intensities, closer 
to the lower boundary of vigorous intensity (6 METs or 6.6 km·h-1) are associated with 
higher vertical impacts (1.90 ± 1.15g) that might reduce the risk of osteoporotic fractures.  
Information about musculoskeletal loading during usual walking and running speeds 
in adults is important for designing exercise training programs aiming to reduce the risk of 
osteoporotic fracture through increased BMD and related measures of bone strength, without 
exposing the individuals to higher risk of falls and osteoporotic injuries. Mean VP values 
were higher compared to AP and lateral axes, increasing from 0.9 ± 0.2g at 4.3 km·h-1 to 1.5 
± 0.4g at 6.1 km·h-1 during velocities associated with walking. In line with Giarmatzis and 
colleagues (Giarmatzis, Jonkers, Wesseling, Van Rossom, & Verschueren, 2015) running 
VPs were approximately 38% higher compared to walking at the same speed (6-7 km·h-1). 
One of the most noticeable differences is the existence of a flight phase in running, rather 
than the double support phase that occurs in walking, which suggest that muscles generate 
greater tensile forces in running (Sasaki & Neptune, 2006). During running, VPs increased 
markedly to 3.1 ± 0.8g at 7.9 km·h-1. The difference in VPs between walking at 6.1 (1.32 ± 
0.3g) to running at 7.9 km·h-1 (137%) was higher than that reported by Giarmatzis 
(Giarmatzis et al., 2015) (57%), based on measurement of hip contact forces (normalized to 
body mass) through calculation of muscle forces along the gait cycle using integrated 
motion capture, but lower than after transitioning from brisk walking to jogging (~320% 





higher magnitude of the VPs) in a small group of young students and recreationally active 
people based on measurement of 3-dimentional tibial acceleration during eigth gait cycles in 
each condition (Montgomery, Abt, Dobson, Smith, & Ditroilo, 2016; Rowlands & Stiles, 
2012). Sample size and participant characteristics (<20 young males and females in the 
previous three studies vs. 82 postmenopausal females in our study), surface (motor driven 
treadmill or 40-m track vs. 20-m track in our study, including turns, accelerations and 
decelerations), footwear (barefoot vs. usual footwear) and data processing and methods of 
measuring impacts between studies might explain some of these inconsistencies in the 
magnitude of the VPs.  
One of the aims of the present study was to identify the factors which predict VPs 
during walking and running, of which the most important were speed and type of 
locomotion. In addition, we observed relatively high variability between individuals (CV = 
18-29%), consistent with the 20-25% variability in hip contact forces at a wide range of 
walking and running speeds found by Giarmatzis and colleagues (Giarmatzis et al., 2015). 
The large variability in VPs between individuals was more pronounced during running at 
high velocities ≥ 6.7 km·h-1, suggesting that individual running characteristics also play an 
important role. For example, participant´s age had a significant but small predictive value, in 
line with previous findings suggesting that shorter stride length observed in elderly 
individuals may result in reduced VPs (Stansfield & Nicol, 2002). Other parameters which 
we evaluated, including body mass and leg strength, were weakly related to VPs in 
multivariable models. In the case of leg strength, attenuation was observed after adjustment 
for velocity, suggesting that leg strength affects VPs through the ability to achieve a certain 
velocity.  





In a previous study, body mass, type of locomotion and hip V acceleration were 
postulated as significant factors for predicting VP ground reaction forces (Neugebauer et al., 
2014). However, speed had a stronger influence on hip contact forces compared to ground 
reaction forces during walking and running, suggesting an influence of muscle activity on 
vertical hip contact forces with increased speed (Giarmatzis et al., 2015). In fact, 
electromyography activity of the rectus femoris and semitendinosus increased almost three-
fold from walking to running (Montgomery et al., 2016; Sasaki & Neptune, 2006). 
Moreover, the results of Giarmatzis and colleagues (Giarmatzis et al., 2015) showed that hip 
adduction moment best predicted both walking (R2 = 0.53-0.78) and running (R2 = 0.63-0.73) 
hip contact forces. Thus conceivably, incorporation of information about biomechanics, and 
more specifically hip abductor function, could further improve the prediction of VPs.  
Observational prospective cohort studies using self-reported questionnaires (Arem et 
al., 2015; Wen et al., 2011) suggest that people meeting current PA guidelines (Garber et al., 
2011; Physical Activity Guidelines Advisory Committee, 2018; Riebe et al., 2017) of 150 
min·wk-1 of MVPA (>3 METs) have reduced risk of all-cause mortality. However, bone 
responds differently to daily PA exposure and current evidence suggest that VPs generated 
by PA play a significant role in bone preservation in postmenopausal women (Katarina T. 
Borer, 2005; K. T. Borer et al., 2007; Hannam et al., 2017; Hatori et al., 1993). The present 
results suggest that V acceleration peaks at 3 METs intensity (0.63 ± 0.18g) are well below 
the suggested 1.5g threshold for preserving bone in pre and post-menopausal women 
(Hannam et al., 2017; Stiles et al., 2017; Vainionpää et al., 2006), whereas walking or 
running at 6 METs threshold (corresponding to 6.6 km·h-1) or above may provide bone-
protective benefits due to higher vertical impacts (1.90 ± 1.15g). However, elderly and 
populations at higher risk of osteoporotic fractures (e.g. severe osteoarthritis, 





postmenopausal women, people with impaired balance and higher risk af falls, hormone 
deficiencies and treatments with glucocorticoids) should progressively increase the 
frequency and the magnitude of the impacts beyond what they can obtain by walking (which 
we showed that is <1.5g) by adding small jumps or short running intervals to their regular 
walks alongside resistance training, considering the U-shaped relationship between physical 
activity, fall risk and osteoporotic injury.  
When mechanical loading is associated with the release of endocrine and muscle-
derived peptides such as oestrogens and growth factors that are released as a function of 
exercise intensity above LT1 (Urhausen, Weiler, Coen, & Kindermann, 1994) it may 
maximize its effects on bone (Edwards, Dennison, Aihie Sayer, Fielding, & Cooper, 2015; 
Pedersen, 2013). In fact, Borer and colleagues (K. T. Borer et al., 2007) and Hatori and 
colleagues (Hatori et al., 1993) showed that fast walking above LT1 (~6.1-7.2 km·h-1 in their 
participants) was effective in increasing BMD and reducing bone resorption markers in 
postmenopausal women in a dose-dependent manner. In our study, LT1 (5.5 ± 0.6 km·h-1 
corresponding to 4.6 ± 0.7 METs or 46.7 ± 8.2%V̇O2max, which matched on average their 
usual walking speed) was still below (1.16 ± 0.08g) the bone protective threshold of 1.5g. 
Exercising at higher intensities (above the 6-MET threshold or ≥ 6.6 km·h-1) might provide 
further benefits for the bone, since accumulating 1-2 minutes/day of vigorous intensity PA, 
equivalent to running close to 10 km·h-1 in pre-menopausal women and jogging at 8 km·h-1 
in post-menopausal women was associated with better bone health, but there was no 
evidence that time spent at lower intensities was related to BMD (Stiles et al., 2017). Based 
on these findings, fast walking or slow jogging that produce vertical impacts beyond 1.5g 
might provide adequate bone protective stimuli for postmenopausal women with similar 
characteristics, since this magnitude of VPs represented an exercise intensity 13% higher 





than the mean LT1 of the study participants (6.24 km·h-1 or 5.38 METs). Progressing to 
higher VPs (~4g) such as jumping exercises might induce even greater benefits in hip BMD 
and architecture (Ahola et al., 2009; Vainionpää et al., 2006; Vainionpaa et al., 2007), 
wihout having to engage in moderate aerobic exercise. This findings will complement the 
tailoring of more complete individualized exercise programs for reducing fracture risk, that 
includes resistance training and balance training activities. 
To the best of our knowledge, this is the first study comparing the accelerations 
produced at a range of walking and running velocities to absolute measures of V̇O2. 
Secondly, the measurement of acceleration peaks in the same way as in population-based 
studies, make results easier to translate to clinical recommendations. Some important 
limitations of the study should also be noted. First, we did not measure muscle activity 
during walking and running that might have contributed to improve the prediction of VPs. It 
has to be also acknowledged that the mechanical loading presented in this study might not 
apply to younger women or men, since body mass, age and muscle activity have been 
suggested as significant predictors of the magnitudes of vertical impacts. Finally, we did not 
directly measure V̇O2 during CVTs for the determination of the LT2. The gold standard 
method for the determination of LT2 requires at least two or three CVT; consequently, 
increasing the time and cost related to cardiopulmonary exercise testing. Instead, we 
accurately determined LT2 velocity from CVTs on the track to derive it´s mechanical 
loading and corresponding energy cost from individual regression equations between VPs 
and measured V̇O2 values at each velocity during the graded test. 
Conclusions 
We found that the magnitude of VPs corresponding to walking at the lower end of 
the recommended moderate intensity target (3METs) by international PA guidelines is well 





below the level previously suggested to be beneficial for BMD and other measures of bone 
strength related to risk of osteoporotic fracture. In contrast, exercising at an intensity close to 
or above the 6-MET upper threshold of moderate intensity (corresponding to brisk walking 
or slow jogging at 6.6 km·h-1) could provide combined benefits in terms of reducing all-
cause mortality and osteoporosis risk. The equation provided in this study to predict VPs 
from speed, type of locomotion and age may guide exercise professionals in the prescription 
of activities intended to reduce the risk of osteoporotic fractures.   
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Table 1. Descriptive characteristics of study participants (n = 82). 
Characteristics  
  Age (years)   59.1 ± 5.4 
Stature (cm) 158.3 ± 5.5 
Body mass (kg) 65.5 ± 11.2 
BMI (kg/m2)   26.1 ± 4.2 
Physical fitness  
Leg press 1RM (kg) 129.7 ± 29.6 
 
LT1 (km·h-1) 5.1 ± 0.6 




Sport trainers/shoe cushioning 50 (61) 
Standard shoe/no cushioning 32 (39) 
  
Note: Values represent mean ± SD. footwear is described as number and 
(percentage) of participants. 
BMI = body mass index, 1RM = 1 repetition maximum strength in kg, LT1 = 
first lactate threshold determined through an incremental shuttle test on track, 
LT2 = maximal lactate steady-state determined through constant velocity tests 
on track. LT2 velocity represents aerobic fitness level of each participant. 
 
  





Table 2. Descriptive characteristics of the sub-group of participants who 
performed additional cardiopulmonary exercise testing (n = 29). 
Characteristics  
  Age (years) 57.2 ± 5.0 
Stature (cm)   158.3 ± 5.5 
Body mass (kg)    65.4 ± 12.2 
BMI (kg/m2)  26.0 ± 4.2 
V̇O2max (METs) 10.0 ± 4.2 
 
[La-]max   7.8 ± 3.2 
 
RERmax   1.22 ± 0.07 
 
RPEmax   8.8 ± 1.9 
HRmax 172.7 ± 11.3 
LT1 (km·h-1)   5.5 ± 0.6 
LT1 (METs)   4.6 ± 0.7 
LT2 (km·h-1) 
 
  7.3 ± 1.1 
LT2 (METs)   7.3 ± 1.9 
  
Note: Values represent mean ± SD.  
BMI = body mass index, MET = rates of energy expenditure (1 MET is 
equivalent to 3.5 ml·kg-1·min-1, [La-]max = maximal blood lactate concentration 
at the end of the test, RER = respiratory exchange ratio, RPE = rating of 
perceived effort (0-10 scale), LT1 = first lactate threshold determined through 
an incremental shuttle test on treadmill, LT2 = maximal lactate steady-state 
velocity obtained on the track. V̇O2 was measured on the treadmill at the 
corresponding LT2 velocity (2-min stages) from the constant velocity tests on 
the track (2 stages of 10min). 
 
  























Supplementary Figure 1 
 
 
